You are here: Industry Insights > Exosome

News List

Exopharm Gains US Patent Enabling Commercial Production of Exosome Medicines prnasia
December 23, 2021
Exopharm Limited (ASX:EX1) has been granted US patent US 11202805 for its LEAP™ exosome purification technology. This patent positions Exopharm as a global leader in meeting the challenge of large-scale...
ILIAS Biologics Inc. demonstrated the therapeutic effect of anti-inflammatory exosomes for ischemia-reperfusion-induced acute kidney injury prnasia
June 29, 2021
Anti-inflammatory exosomes could have a place in treating acute kidney injury (AKI) caused by ischemia repercussion injury (IRI), according to a study done by ILIAS Biologics, Inc. in collaboration with Yonsei University of Seoul, South Korea.
$109.2 Million Worldwide Exosome Research Products Industry to 2027 - Impact of COVID-19 on the Market prnewswire
May 19, 2021
The "Exosome Research Products - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Evox raises £69.2m to advance exosome-based therapeutics pipeline pharmatimes
February 19, 2021
Oxford-based biotech company Evox Therapeutics has completed a Series C financing round, announcing that it has raised £69.2m ($95.4m) following ‘high demand’ from existing and new investors.
ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States prnasia
July 08, 2020
ILIAS Biologics Inc. (the "Company" or "ILIAS"), a global leader in exosome-based therapeutics, announced today that the Company has been granted a key exosome engineering patent by the United States Patent and Trademark Office (USPTO).
Exosomes promote remarkable recovery in stroke worldpharmanews
January 15, 2020
It's been almost a quarter century since the first drug was approved for stroke. But what's even more striking is that only a single drug remains approved today.
Macrogen, Exosome Plus to jointly develop exosome-based diagnostic & treatment solutions biospectrumasia
April 25, 2019
Under the newly signed contract, Exosome Plus will exclusively supply its high-efficiency exosome isolation kit ‘Exo2D' to Macrogen for one year.
Jazz and Codiak collaborate on creating engineered exosomes for cancer pharmaceutical-technology
January 07, 2019
Jazz Pharmaceuticals has announced a collaboration with Codiak Biosciences to research, develop and commercialise cancer therapies created through engineering exosomes......
Stem Cell Medicine Licenses Exosome Technology from Ramot at Tel Aviv University americanpharmaceuticalreview
January 03, 2019
Stem Cell Medicine has licensed an exosomes based technology for the treatment of neurodegenerative and neuropsychiatric indications, specifically, autism spectrum disorder (ASD).....
Evox bags grant from Duchenne UK to engineer exosomes pharmatimes
November 14, 2018
Evox Therapeutics has secured £655,000 in funding from Duchenne UK, to support exploration of its exosome-based therapeutic platform for the condition.